Clinical Trial Update: A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports completion of a 47-hour occlusive cutaneous patch test in adults with dry/atopic skin (eczema). The study is sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Reckitt Benckiser Healthcare (UK) Limited | Conditions: Eczema | Phase 1 | Status: COMPLETED